Answers are grounded in this paper and cite their sources.
Background: Recently, combined photodynamic therapy (PDT) and photothermal therapy (PTT) has become a desired treatment for cancer. However, the development of economic, high-efficiency, and safe photosensitizers/photothermal agents remains a significant challenge. Methods: A novel nanocomposite has been developed via the assembly of iron oxide carbon dot (Fe 3 O 4 -CDs) nanoparticles and black phosphorus quantum dots (genipin [GP]-polyglutamic acid [PGA]-Fe 3 O 4 [email protected] ), and this nanocomposite shows a broad light-absorption band and a photodegradable character. Results: In vitro and in vivo assays indicated that GP-PGA-Fe 3 O 4 [email protected] were highly biocompatible and exhibited excellent tumor-inhibition efficacy, due to the synergistic PTT and PDT via a near-infrared laser. Importantly, in vivo tumor magnetic resonance imaging (MRI) results illustrated that GP-PGA-Fe 3 O 4 [email protected] can be specifically applied for enhanced T 2 MRI of tumors. This work presents the first combined application of a PDT and PTT effect deriving from BPQDs and MRI from Fe 3 O 4 -CDs, which may promote utilization of black BPQDs in biomedicine. Conclusion: As expected, GP-PGA-Fe 3 O 4 [email protected] displayed a dramatically enhanced ability to destroy tumor cells, due to the synergistic combination of PTT and PDT.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: